118 related articles for article (PubMed ID: 7007067)
1. Residual marrow damage following therapy with cyclophosphamide.
Fried W; Barone J
Exp Hematol; 1980 May; 8(5):610-4. PubMed ID: 7007067
[TBL] [Abstract][Full Text] [Related]
2. [Effect of cyclophosphamide on the bone marrow hematopoiesis in the mouse].
Xie RF
Zhonghua Zhong Liu Za Zhi; 1985 Nov; 7(6):435-7. PubMed ID: 3836845
[TBL] [Abstract][Full Text] [Related]
3. Late effects of chemotherapy on hematopoietic progenitor cells.
Fried W; Adler S
Exp Hematol; 1985; 13 Suppl 16():49-56. PubMed ID: 3886419
[TBL] [Abstract][Full Text] [Related]
4. Effect of low frequency low energy pulsing electromagnetic fields on mice injected with cyclophosphamide.
Cadossi R; Zucchini P; Emilia G; Franceschi C; Cossarizza A; Santantonio M; Mandolini G; Torelli G
Exp Hematol; 1991 Mar; 19(3):196-201. PubMed ID: 1995311
[TBL] [Abstract][Full Text] [Related]
5. Hemopoietic activity in bone marrow chimeras prepared with total lymphoid irradiation (TLI).
Slavin S; Seidel HJ
Exp Hematol; 1982 Feb; 10(2):206-16. PubMed ID: 7037437
[TBL] [Abstract][Full Text] [Related]
6. Effect of cytokine treatment (granulocyte colony-stimulating factor and stem cell factor) on hematopoiesis and the circulating pool of hematopoietic stem cells in mice.
Drize N; Chertkov J; Samoilina N; Zander A
Exp Hematol; 1996 Jun; 24(7):816-22. PubMed ID: 8647232
[TBL] [Abstract][Full Text] [Related]
7. The possibility of assaying Wistar rat bone marrow CFUs in a xenogeneic (rat-to-mouse) system.
Fohlmeister I; Hohentanner O
Nat Immun Cell Growth Regul; 1985; 4(4):221-8. PubMed ID: 2866442
[TBL] [Abstract][Full Text] [Related]
8. Decrease in the ability of bone marrow CFUs to produce macroscopic colonies of haematopoietic tissue in the spleens of partially irradiated young rats.
Vacek A; Bartonícková A; Rotkovská D
Folia Biol (Praha); 1979; 25(3):188-97. PubMed ID: 385373
[TBL] [Abstract][Full Text] [Related]
9. [Recovery from cyclophosphamide-induced myelosuppression accelerated by bestatin].
Uchida K; Kohi F; Yorimitsu S; Takahashi I; Kitajima K; Kimura I
Gan To Kagaku Ryoho; 1982 Feb; 9(2):220-4. PubMed ID: 7184398
[TBL] [Abstract][Full Text] [Related]
10. Combined interleukin 1 beta/interleukin 2 treatment in mice: synergistic myelostimulatory activity and protection against cyclophosphamide-induced myelosuppression.
Proietti E; Tritarelli E; Gabriele L; Testa U; Greco G; Pelosi E; Gabbianelli M; Belardelli F; Peschle C
Cancer Res; 1993 Feb; 53(3):569-76. PubMed ID: 8425189
[TBL] [Abstract][Full Text] [Related]
11. Combined interleukin-1 beta/interleukin-6 treatment in mice: synergistic myelostimulatory activity and myelorestorative effect after cyclophosphamide-induced myelosuppression.
Tritarelli E; Greco G; Testa U; Belardelli F; Peschle C; Proietti E
Cancer Res; 1994 Dec; 54(24):6469-76. PubMed ID: 7987845
[TBL] [Abstract][Full Text] [Related]
12. Lithium stimulates the recovery of granulopoiesis following acute radiation injury.
Gallicchio VS; Chen MG; Watts TD; Gamba-Vitalo C
Exp Hematol; 1983 Jul; 11(6):553-63. PubMed ID: 6617790
[TBL] [Abstract][Full Text] [Related]
13. Profoundly reduced neovascularization capacity of bone marrow mononuclear cells derived from patients with chronic ischemic heart disease.
Heeschen C; Lehmann R; Honold J; Assmus B; Aicher A; Walter DH; Martin H; Zeiher AM; Dimmeler S
Circulation; 2004 Apr; 109(13):1615-22. PubMed ID: 15037527
[TBL] [Abstract][Full Text] [Related]
14. The effect of Damvar on the formation of hemopoietic splenic colonies in mice, and on the peripheral blood picture in rats and dogs.
Hrubá A; Paluska E; Berger J; Pujman V; Chudomel V
Czech Med; 1981; 4(1-2):25-31. PubMed ID: 7021097
[TBL] [Abstract][Full Text] [Related]
15. In vitro and in vivo hematopoietic activities of Betafectin PGG-glucan.
Patchen ML; Vaudrain T; Correira H; Martin T; Reese D
Exp Hematol; 1998 Dec; 26(13):1247-54. PubMed ID: 9845381
[TBL] [Abstract][Full Text] [Related]
16. Hematopoietic stem cell deficit of transplanted bone marrow previously exposed to cytotoxic agents.
Neben S; Hellman S; Montgomery M; Ferrara J; Mauch P
Exp Hematol; 1993 Jan; 21(1):156-62. PubMed ID: 8435103
[TBL] [Abstract][Full Text] [Related]
17. NTP technical report on the toxicity studies of Riddelliine (CAS No. 23246-96-0) Administered by Gavage to F344 Rats and B6C3F1 Mice.
Chan P
Toxic Rep Ser; 1993 Dec; 27():1-D9. PubMed ID: 12209179
[TBL] [Abstract][Full Text] [Related]
18. Alterations in both the hematopoietic microenvironment and the progenitor cell population follow the recovery from myeloablative therapy and bone marrow transplantation.
Novitzky N; Mohamed R
Exp Hematol; 1995 Dec; 23(14):1661-6. PubMed ID: 8542962
[TBL] [Abstract][Full Text] [Related]
19. Leukemia inhibitory factor induces in vivo expansion of bone marrow progenitor cells that accelerate hematopoietic reconstitution but do not enhance radioprotection in lethally irradiated mice.
Pruijt JF; Lindley IJ; Heemskerk DP; Willemze R; Fibbe WE
Stem Cells; 1997; 15(1):50-5. PubMed ID: 9007222
[TBL] [Abstract][Full Text] [Related]
20. Ciprofloxacin enhances hematopoiesis and the peritoneal neutrophil function in lethally irradiated, bone marrow-transplanted mice.
Kletter Y; Singer A; Nagler A; Slavin S; Fabian I
Exp Hematol; 1994 Apr; 22(4):360-5. PubMed ID: 8150034
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
